Skip to main content
Top
Published in: Clinical and Experimental Nephrology 3/2011

01-06-2011 | Case Report

A Japanese case of proteinase 3 antineutrophil cytoplasmic autoantibody-associated pauci-immune-type crescentic glomerulonephritis without valvular endocarditis

Authors: Satoshi Morimoto, Fumitaka Nakajima, Tatsuyori Morita, Kazunori Someya, Makiko Kusabe, Mitsutaka Nakahigashi, Takatomi Yurugi, Masayoshi Fukui, Takayuki Okamoto, Fusakazu Jo, Nagaoki Toyoda, Toshiji Iwasaka

Published in: Clinical and Experimental Nephrology | Issue 3/2011

Login to get access

Abstract

A 74-year-old male without recent medical treatment visited our hospital complaining of fever and lack of appetite. Upon examination severe azotemia, proteinuria, and urinary occult blood were noted, and the patient was admitted. Results of a blood test showed that his proteinase 3 antineutrophil cytoplasmic autoantibody (PR3-ANCA) level was high. A transthoracic echocardiogram indicated normal cardiac function and no valvular regurgitation or stenosis. Necrotizing glomerulonephritis accompanied by cellular crescentic bodies, but not granuloma, was noted on renal biopsy. An immunofluorescence study demonstrated no immunofluorescence staining in the glomerulus or in the tubulointerstitial or vascular compartments. No lesion was present in the lung or upper respiratory tract. The patient was diagnosed with PR3-ANCA-associated pauci-immune-type crescentic glomerulonephritis and treated with steroids. This treatment resulted in rapid normalization of C-reactive protein, and the PR3-ANCA level slowly decreased and converted to negative. The renal function, however, did not improve, and maintenance dialysis was introduced. No pulmonary or upper airway lesion has developed during 18 months of follow-up. PR3-ANCA-positive crescentic glomerulonephritis accompanied by valvular endocarditis has been described by several reports in Japan; however, this case was not complicated by valvular endocarditis. To our knowledge, this is the 4th case report describing PR3-ANCA-associated crescentic glomerulonephritis in Japan.
Literature
1.
go back to reference Jennette JC, Thomas DB. Pauci-immune and antineutrophil cytoplasmic autoantibody-mediated crescentic glomerulonephritis and vasculits. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editor. Heptinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 643–674. Jennette JC, Thomas DB. Pauci-immune and antineutrophil cytoplasmic autoantibody-mediated crescentic glomerulonephritis and vasculits. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editor. Heptinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 643–674.
2.
go back to reference Joh K, Muso E, Shigematsu H, Nose M, Nagata M, Arimura Y, Yumura W, Wada T, Nitta K, Makino H, Taguma Y, Kaneoka H, Suzuki Y, Kobayashi M, Koyama A, Usui J, Hashimoto H, Ozaki S, Tomino Y, Yamagata K. Renal pathology of ANCA-related vasculitis: proposal for standardization of pathological diagnosis in Japan. Clin Exp Nephrol. 2008;12:277–91.CrossRef Joh K, Muso E, Shigematsu H, Nose M, Nagata M, Arimura Y, Yumura W, Wada T, Nitta K, Makino H, Taguma Y, Kaneoka H, Suzuki Y, Kobayashi M, Koyama A, Usui J, Hashimoto H, Ozaki S, Tomino Y, Yamagata K. Renal pathology of ANCA-related vasculitis: proposal for standardization of pathological diagnosis in Japan. Clin Exp Nephrol. 2008;12:277–91.CrossRef
3.
go back to reference Koyama A, Yamagata K, Makino H, Arimura Y, Wada T, Nitta K, Nihei H, Muso E, Taguma Y, Shigematsu H, Sakai H, Tomino Y, Matsuo S, Japan RPGN Registry Group. A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol. 2009;13:633–50.CrossRef Koyama A, Yamagata K, Makino H, Arimura Y, Wada T, Nitta K, Nihei H, Muso E, Taguma Y, Shigematsu H, Sakai H, Tomino Y, Matsuo S, Japan RPGN Registry Group. A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol. 2009;13:633–50.CrossRef
4.
go back to reference Haseyama T, Imai H, Komatsuda A, Hamai K, Ohtani H, Kibira S, et al. Proteinase-3-antineutrophil cytoplasmic antibody (PR3-ANCA) positive crescentic glomerulonephritis in a patient with Down’s syndrome and infectious endocarditis. Nephrol Dial Transplant. 1998;13(8):2142–6.CrossRef Haseyama T, Imai H, Komatsuda A, Hamai K, Ohtani H, Kibira S, et al. Proteinase-3-antineutrophil cytoplasmic antibody (PR3-ANCA) positive crescentic glomerulonephritis in a patient with Down’s syndrome and infectious endocarditis. Nephrol Dial Transplant. 1998;13(8):2142–6.CrossRef
5.
go back to reference Osafumi K, Takeoka H, Kanamori H, Koshiyama H, Hirose K, Hanada M, Kimura R, Ando F, Kanatsu K. Crescentic glomerulonephritis associated with infective endocarditis: renal recovery after immediate surgical intervention. Clin Exp Nephrol. 2000;4:329–34.CrossRef Osafumi K, Takeoka H, Kanamori H, Koshiyama H, Hirose K, Hanada M, Kimura R, Ando F, Kanatsu K. Crescentic glomerulonephritis associated with infective endocarditis: renal recovery after immediate surgical intervention. Clin Exp Nephrol. 2000;4:329–34.CrossRef
6.
go back to reference Fukuda M, Motokawa M, Usami T, Oikawa T, Morozumi K, Yoshida A, et al. PR3-ANCA-positive crescentic necrotizing glomerulonephritis accompanied by isolated pulmonic valve infective endocarditis, with reference to previous reports of renal pathology. Clin Nephrol. 2006;66(3):202–9.CrossRef Fukuda M, Motokawa M, Usami T, Oikawa T, Morozumi K, Yoshida A, et al. PR3-ANCA-positive crescentic necrotizing glomerulonephritis accompanied by isolated pulmonic valve infective endocarditis, with reference to previous reports of renal pathology. Clin Nephrol. 2006;66(3):202–9.CrossRef
7.
go back to reference Iwatani H, Nagasawa Y, Oka K, Isaka Y, Imai E. Valvular injury in a patient with PR3-ANCA-associated glomerulonephritis. Nat Clin Pract Nephrol. 2008;4(10):576–82.CrossRef Iwatani H, Nagasawa Y, Oka K, Isaka Y, Imai E. Valvular injury in a patient with PR3-ANCA-associated glomerulonephritis. Nat Clin Pract Nephrol. 2008;4(10):576–82.CrossRef
8.
go back to reference Oka K, Moriyama T, Izumi M, Sugiura T, Nakamura H, Nagatoya K, et al. A case of relapse of C-ANCA-associated glomerulonephritis in post-transplant patients. Clin Transplant. 2000;14(Suppl 3):33–6.CrossRef Oka K, Moriyama T, Izumi M, Sugiura T, Nakamura H, Nagatoya K, et al. A case of relapse of C-ANCA-associated glomerulonephritis in post-transplant patients. Clin Transplant. 2000;14(Suppl 3):33–6.CrossRef
9.
go back to reference Yasuda M, Isshiki K, Sakaguchi M, Kanasaki M, Kato N, Yamahara K, Takagi A, Iwai T, Ueda H, Araki S, Sugimoto T, Okada Y, Uzu T. A hemodialysis patient with PR3-ANCA/MPO-ANCA-positive cresentic glomerulonephritis and extrapulmonary lymph node tuberculosis. Tousekikaishi. 2009;42:965–72. Yasuda M, Isshiki K, Sakaguchi M, Kanasaki M, Kato N, Yamahara K, Takagi A, Iwai T, Ueda H, Araki S, Sugimoto T, Okada Y, Uzu T. A hemodialysis patient with PR3-ANCA/MPO-ANCA-positive cresentic glomerulonephritis and extrapulmonary lymph node tuberculosis. Tousekikaishi. 2009;42:965–72.
10.
go back to reference Sakaguchi Y, Niihata K, Yasuda K, Shimomura A, Uehata T, Inoue K, Kaneko T, Shoji T, Tsubakihara Y, Okada N. An autopsy case of PR3-ANCA-associated vasculitis complicated with rectus muscle hematoma. Jpn J Nephrol. 2009;51:550–6. Sakaguchi Y, Niihata K, Yasuda K, Shimomura A, Uehata T, Inoue K, Kaneko T, Shoji T, Tsubakihara Y, Okada N. An autopsy case of PR3-ANCA-associated vasculitis complicated with rectus muscle hematoma. Jpn J Nephrol. 2009;51:550–6.
11.
go back to reference Wegener F. Uber eine eigenartige rhinogene granulomatose mit besonderer beteiligung des arterien system und der nieren. Beitr Pathol Anat. 1939;102:36–8. Wegener F. Uber eine eigenartige rhinogene granulomatose mit besonderer beteiligung des arterien system und der nieren. Beitr Pathol Anat. 1939;102:36–8.
12.
go back to reference Carrington CB, Liebow A. Limited forms of angiitis and granulomatosis of Wegener’s type. Am J Med. 1966;41:497–527.CrossRef Carrington CB, Liebow A. Limited forms of angiitis and granulomatosis of Wegener’s type. Am J Med. 1966;41:497–527.CrossRef
13.
go back to reference Boubenider SA, Akhtar M, Nyman R. Wegener’s granulomatosis limited to the kidney as a masslike lesion. Nephron. 1994;68:500–4.CrossRef Boubenider SA, Akhtar M, Nyman R. Wegener’s granulomatosis limited to the kidney as a masslike lesion. Nephron. 1994;68:500–4.CrossRef
14.
go back to reference Kallenberg CG, Brouwer E, Weening JJ, Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int. 1994;46:1–15.CrossRef Kallenberg CG, Brouwer E, Weening JJ, Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int. 1994;46:1–15.CrossRef
15.
go back to reference Matsumoto Y, Inaba Y, Nakayama T, Tamakoshi A, Ohno Y, Kobayashi S, Hashimoto H, Koike T, Miyasaka N. Nationwide epidemiological survey of refractory vasculitis (anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, anti-phospholipid syndrome and temporal arteritis) in Japan. Annual report of the research committee on intractable vasculitides, the Ministry of Health and Welfare of Japan [in Japanese], Tokyo. 1998. p. 15–23. Matsumoto Y, Inaba Y, Nakayama T, Tamakoshi A, Ohno Y, Kobayashi S, Hashimoto H, Koike T, Miyasaka N. Nationwide epidemiological survey of refractory vasculitis (anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, anti-phospholipid syndrome and temporal arteritis) in Japan. Annual report of the research committee on intractable vasculitides, the Ministry of Health and Welfare of Japan [in Japanese], Tokyo. 1998. p. 15–23.
16.
go back to reference Sakai K, Kurokawa K, Koyama A, Arimura Y, Kida H, Shigematsu S, Suzuki R, Nihei H, Makino M, Ueda N, Kawamura T, Gejyo F, Saito T, Harada T, Hiki Y, Yoshida M. Committee for the Guidelines on Diagnosis and Therapy of Rapidly Progressive Glomerulonephritis: The guidelines for the management of rapidly progressive glomerulonephritis (in Japanese). Jpn J Nephrol. 2002;44:55–83. Sakai K, Kurokawa K, Koyama A, Arimura Y, Kida H, Shigematsu S, Suzuki R, Nihei H, Makino M, Ueda N, Kawamura T, Gejyo F, Saito T, Harada T, Hiki Y, Yoshida M. Committee for the Guidelines on Diagnosis and Therapy of Rapidly Progressive Glomerulonephritis: The guidelines for the management of rapidly progressive glomerulonephritis (in Japanese). Jpn J Nephrol. 2002;44:55–83.
17.
go back to reference Watts RA, Lane S, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum. 2000;43:414–9.CrossRef Watts RA, Lane S, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum. 2000;43:414–9.CrossRef
18.
go back to reference Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum. 2005;53:93–9.CrossRef Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum. 2005;53:93–9.CrossRef
19.
go back to reference Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, Plaisance M, Pusey CD, Jayne DR, Pan-Thames Renal Research Group. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003;41:776–84.CrossRef Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, Plaisance M, Pusey CD, Jayne DR, Pan-Thames Renal Research Group. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003;41:776–84.CrossRef
20.
go back to reference Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 2002;61:80–9.CrossRef Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 2002;61:80–9.CrossRef
21.
go back to reference Westman KW, Bygren PG, Olsson H, Ranstam J, Wieslander J. Relapse rate, renal survival, and cancer morbidity in patients with Wegener’s granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol. 1998;9:842–52.PubMed Westman KW, Bygren PG, Olsson H, Ranstam J, Wieslander J. Relapse rate, renal survival, and cancer morbidity in patients with Wegener’s granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol. 1998;9:842–52.PubMed
22.
go back to reference Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996;7:23–32.PubMed Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996;7:23–32.PubMed
23.
go back to reference Fujimoto S, Uezeno S, Hisanaga S, Fukudome K, Kobayashi S, Suzuki K, Hashimoto H, Nakao H, Nunoi H. Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population-based, retrospective, epidemiologic survey in Japan. Clin J Am Soc Nephrol. 2006;1:1016–22.CrossRef Fujimoto S, Uezeno S, Hisanaga S, Fukudome K, Kobayashi S, Suzuki K, Hashimoto H, Nakao H, Nunoi H. Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population-based, retrospective, epidemiologic survey in Japan. Clin J Am Soc Nephrol. 2006;1:1016–22.CrossRef
24.
go back to reference Ueda H, Ishimura E, Yunoki T, Tsuchida T, Matsumoto N, Jono S, Imanishi Y, Inaba M, Nishizawa Y. Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCA. Clin Exp Nephrol. 2005;9:332–4.CrossRef Ueda H, Ishimura E, Yunoki T, Tsuchida T, Matsumoto N, Jono S, Imanishi Y, Inaba M, Nishizawa Y. Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCA. Clin Exp Nephrol. 2005;9:332–4.CrossRef
25.
go back to reference Franssen CF, Stegeman CA, Kallenberg CG, Gans RO, De Jong PE, Hoorntje SJ, Tervaert JW. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int. 2000;57:2195–206.CrossRef Franssen CF, Stegeman CA, Kallenberg CG, Gans RO, De Jong PE, Hoorntje SJ, Tervaert JW. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int. 2000;57:2195–206.CrossRef
26.
go back to reference Jennette JC, Wilkman AS, Falk RJ. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol. 1989;135:921–30.PubMedPubMedCentral Jennette JC, Wilkman AS, Falk RJ. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol. 1989;135:921–30.PubMedPubMedCentral
27.
go back to reference Fienberg R, Mark EJ, Goodman M, McCluskey RT, Niles JL. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener’s (pathergic) granulomatosis and related forms of vasculitis. Hum Pathol. 1993;24:160–8.CrossRef Fienberg R, Mark EJ, Goodman M, McCluskey RT, Niles JL. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener’s (pathergic) granulomatosis and related forms of vasculitis. Hum Pathol. 1993;24:160–8.CrossRef
28.
go back to reference Haubitz M. ANCA-associated vasculitis: diagnosis, clinical characteristics and treatment. Vasa. 2007;36:81–9.CrossRef Haubitz M. ANCA-associated vasculitis: diagnosis, clinical characteristics and treatment. Vasa. 2007;36:81–9.CrossRef
Metadata
Title
A Japanese case of proteinase 3 antineutrophil cytoplasmic autoantibody-associated pauci-immune-type crescentic glomerulonephritis without valvular endocarditis
Authors
Satoshi Morimoto
Fumitaka Nakajima
Tatsuyori Morita
Kazunori Someya
Makiko Kusabe
Mitsutaka Nakahigashi
Takatomi Yurugi
Masayoshi Fukui
Takayuki Okamoto
Fusakazu Jo
Nagaoki Toyoda
Toshiji Iwasaka
Publication date
01-06-2011
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 3/2011
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-011-0407-3

Other articles of this Issue 3/2011

Clinical and Experimental Nephrology 3/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.